CollPlant Biotechnologies Analyst Ratings
CollPlant Biotechnologies Analyst Ratings
While ratings are subjective and will change, the latest CollPlant Biotechnologies (CLGN) rating was a initiated with a price target of $0.00 to $22.75. The current price CollPlant Biotechnologies (CLGN) is trading at is $11.80, which is within the analyst's predicted range.| Date | Upside/Downside | Analyst Firm | Price Target Change | Rating Change | Previous / Current Rating |
|---|---|---|---|---|---|
| 02/17/2023 | 92.8% | Alliance Global Partners | → $22.75 | Initiates Coverage On | → Buy |
| 02/09/2021 | 120.34% | HC Wainwright & Co. | $13 → $26 | Maintains | Buy |
| 05/28/2020 | 10.17% | HC Wainwright & Co. | $11 → $13 | Reiterates | → Buy |
| 04/03/2020 | -6.78% | HC Wainwright & Co. | $7 → $11 | Reiterates | → Buy |
| 12/18/2018 | -40.68% | HC Wainwright & Co. | → $7 | Initiates Coverage On | → Buy |
| 日期 | 上/下行 | 分析師公司 | 价格目標變更 | 評級變更 | 上一頁/目前評分 |
|---|---|---|---|---|---|
| 02/17/2023 | 92.8% | 聯盟全球夥伴 | → 二七十五美元 | 啟動覆蓋範圍 | → 購買 |
| 2021 年 9 月 2 日 | 120.34% | HC 溫賴特 & 有限公司. | 十三美元 → 二十六美元 | 維護 | 購買 |
| 05/28/2020 | 10.17% | HC 溫賴特 & 有限公司. | 十一美元 → 十三美元 | 重申 | → 購買 |
| 2020 年 3 月 4 日 | -6.78% | HC 溫賴特 & 有限公司. | 7 美元 → 11 美元 | 重申 | → 購買 |
| 12/18/2018 | -40.68% | HC 溫賴特 & 有限公司. | → 7 美元 | 啟動覆蓋範圍 | → 購買 |
What is the target price for CollPlant Biotechnologies (CLGN)?
科林生物技術 (CLGN) 的目標價格是多少？
The latest price target for CollPlant Biotechnologies (NASDAQ: CLGN) was reported by Alliance Global Partners on February 17, 2023. The analyst firm set a price target for $22.75 expecting CLGN to rise to within 12 months (a possible 92.80% upside). 1 analyst firms have reported ratings in the last year.
全球合作夥伴聯盟於 2023 年 2 月 17 日報告了科林生物技術（納斯達克股票代碼：CLGN）的最新價格目標。該分析師公司設定了 22.75 美元的目標價格，預計 CLGN 將在 12 個月內上升至（可能是 92.80％ 的上行情況）。1 家分析師公司在去年報告了評級。
What is the most recent analyst rating for CollPlant Biotechnologies (CLGN)?
科林生物技術（CLGN）的最新分析師評級是什麼？
The latest analyst rating for CollPlant Biotechnologies (NASDAQ: CLGN) was provided by Alliance Global Partners, and CollPlant Biotechnologies initiated their buy rating.
科林生物技術（納斯達克股票代碼：CLGN）的最新分析師評級由聯盟全球合作夥伴提供，科林生物技術發起了他們的購買評級。
When is the next analyst rating going to be posted or updated for CollPlant Biotechnologies (CLGN)?
什麼時候是下一個分析師評級將被張貼或更新科林生物技術 (CLGN)?
Analysts arrive at stock ratings after doing extensive research, which includes going through public financial statements, talking to executives and customers of CollPlant Biotechnologies, and listening in to earnings conference calls. Most analysts do this every three months, so you should get 4 ratings per company per firm each year. The last rating for CollPlant Biotechnologies was filed on February 17, 2023 so you should expect the next rating to be made available sometime around February 17, 2024.
分析師在做廣泛的研究後到達股票評級, 其中包括通過公共財務報表去, 交談的高管和客戶 CollLplant 生物技術, 並在收益電話會議聽.大多數分析師每三個月這樣做一次，因此您應該每年每家公司獲得 4 個評級。對於柯林生物技術的最後評級提交二月 17, 2023 所以你應該期望下一個評級將在二月左右的某個時候提供 17, 2024.
Is the Analyst Rating CollPlant Biotechnologies (CLGN) correct?
分析師評級科爾植物生物技術（CLGN）是否正確？
While ratings are subjective and will change, the latest CollPlant Biotechnologies (CLGN) rating was a initiated with a price target of $0.00 to $22.75. The current price CollPlant Biotechnologies (CLGN) is trading at is $11.80, which is within the analyst's predicted range.
雖然評級是主觀的，並且會發生變化，但最新的科爾植物生物技術（CLGN）評級是啟動的，目標價格為 0.00 美元至 22.75 美元。目前的價格科爾植物生物技術（CLGN）的交易價格為 $11.80，這是分析師的預測範圍內。
